# HS 294150 Erythromycin And Its Derivatives global trade data...

Reported global trade in erythromycin and its derivatives: salts thereof reached $483.0M in 2024, with five-year annual growth of -0.9%.

## Annual trade evidence

| Year | Global trade | Year-on-year growth | 3-year growth |
| --- | --- | --- | --- |
| 2013 | $946.5M | -11.5% | -5.1% |
| 2014 | $733.7M | -22.5% | -17.5% |
| 2015 | $527.5M | -28.1% | -21% |
| 2016 | $570.3M | +8.1% | -15.5% |
| 2017 | $571.5M | +0.2% | -8% |
| 2018 | $557.4M | -2.5% | +1.9% |
| 2019 | $505.8M | -9.3% | -3.9% |
| 2020 | $505.2M | -0.1% | -4% |
| 2021 | $412.9M | -18.3% | -9.5% |
| 2022 | $452.9M | +9.7% | -3.6% |
| 2023 | $555.5M | +22.7% | +3.2% |
| 2024 | $483.0M | -13.1% | +5.4% |

## Leading buyer markets

| Buyer market | Latest imports | 5-year growth | Suppliers |
| --- | --- | --- | --- |
| India | $131.6M | +3.5% | 15 |
| Japan | $37.1M | -2.3% | 13 |
| Croatia | $23.7M | -4.9% | 5 |
| Republic of Korea | $21.8M | +6.4% | 16 |
| Netherlands | $17.0M | -18.8% | 14 |
| Turkey | $14.8M | +0.4% | 18 |
| Pakistan | $13.9M | -1.3% | 7 |
| USA | $13.6M | -4.4% | 14 |
| Mexico | $12.1M | +4.3% | 21 |
| Italy | $10.7M | +0.6% | 13 |
| Romania | $10.6M | +11% | 8 |
| Iran | $10.4M | -13.6% | 9 |

_Source: reported merchandise trade data. Updated 2026-08-14._